Ohio Public Employees Retirement System (OPERS)’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-60,000	Closed	-$2.31M	–	2017
2023 Q2	$2.31M	Buy	+60,000	New	+$1.54M	0.01%	949
2020 Q4	–	Sell	-3,642	Closed	-$44K	–	2008
2020 Q3	$44K	Hold	3,642	–	–	﹤0.01%	1749
2020 Q2	$42K	Hold	3,642	–	–	﹤0.01%	1750
2020 Q1	$50K	Buy	3,642 +3,042	+507%	+$36K	﹤0.01%	1597
2019 Q4	$4K	Hold	600	–	–	﹤0.01%	1862
2019 Q3	$3K	Buy	+600	New	+$3.98K	﹤0.01%	1950

Ohio Public Employees Retirement System (OPERS)'s KDNY Position: Q3 2023 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 60,000 shares — an estimated $2.31M sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in KDNY in Q3 2019 and held it in 6 quarters. The position peaked at $2.31M in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

Ohio Public Employees Retirement System (OPERS) reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Ohio Public Employees Retirement System (OPERS) sold 60,000 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $2.31M.
Ohio Public Employees Retirement System (OPERS) first reported a position in Chinook Therapeutics, Inc. Common Stock in Q3 2019 and held it in 6 quarters.
Ohio Public Employees Retirement System (OPERS)'s Chinook Therapeutics, Inc. Common Stock position peaked at $2.31M in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q3 2023, filed 15 Nov 2023.